620 related articles for article (PubMed ID: 18307680)
1. Role of alpha1-blockers in chronic prostatitis syndromes.
Nickel JC
BJU Int; 2008 Mar; 101 Suppl 3():11-6. PubMed ID: 18307680
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy strategies in chronic prostatitis/chronic pelvic pain syndrome management.
Murphy AB; Nadler RB
Expert Opin Pharmacother; 2010 Jun; 11(8):1255-61. PubMed ID: 20429665
[TBL] [Abstract][Full Text] [Related]
3. The effect of alpha-adrenergic antagonists in chronic prostatitis/chronic pelvic pain syndrome: a meta-analysis of randomized controlled trials.
Yang G; Wei Q; Li H; Yang Y; Zhang S; Dong Q
J Androl; 2006; 27(6):847-52. PubMed ID: 16870951
[TBL] [Abstract][Full Text] [Related]
4. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial.
Nickel JC; Narayan P; McKay J; Doyle C
J Urol; 2004 Apr; 171(4):1594-7. PubMed ID: 15017228
[TBL] [Abstract][Full Text] [Related]
5. Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial.
Cheah PY; Liong ML; Yuen KH; Teh CL; Khor T; Yang JR; Yap HW; Krieger JN
J Urol; 2003 Feb; 169(2):592-6. PubMed ID: 12544314
[TBL] [Abstract][Full Text] [Related]
6. Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial.
Nickel JC; Downey J; Johnston B; Clark J;
J Urol; 2001 May; 165(5):1539-44. PubMed ID: 11342913
[TBL] [Abstract][Full Text] [Related]
7. Frequent ejaculation associated free radical and lactic acid accumulation cause noninfectious inflammation and muscle dysfunction: a potential mechanism for symptoms in Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
Peng H; Chen Q; Tan Y
Med Hypotheses; 2009 Sep; 73(3):372-3. PubMed ID: 19435656
[TBL] [Abstract][Full Text] [Related]
8. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.
Mehik A; Alas P; Nickel JC; Sarpola A; Helström PJ
Urology; 2003 Sep; 62(3):425-9. PubMed ID: 12946740
[TBL] [Abstract][Full Text] [Related]
9. Anti-nanobacterial therapy for men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: preliminary experience.
Shoskes DA; Thomas KD; Gomez E
J Urol; 2005 Feb; 173(2):474-7. PubMed ID: 15643213
[TBL] [Abstract][Full Text] [Related]
10. Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT.
Shoskes DA; Nickel JC; Kattan MW
Urology; 2010 Jun; 75(6):1249-53. PubMed ID: 20363491
[TBL] [Abstract][Full Text] [Related]
11. Failure of a monotherapy strategy for difficult chronic prostatitis/chronic pelvic pain syndrome.
Nickel JC; Downey J; Ardern D; Clark J; Nickel K
J Urol; 2004 Aug; 172(2):551-4. PubMed ID: 15247727
[TBL] [Abstract][Full Text] [Related]
12. Identification, pharmacologic considerations, and management of prostatitis.
Schiller DS; Parikh A
Am J Geriatr Pharmacother; 2011 Feb; 9(1):37-48. PubMed ID: 21459307
[TBL] [Abstract][Full Text] [Related]
13. Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome.
Xia D; Wang P; Chen J; Wang S; Jiang H
Chin Med J (Engl); 2011 Jul; 124(14):2158-61. PubMed ID: 21933619
[TBL] [Abstract][Full Text] [Related]
14. A placebo-controlled comparison of the efficiency of triple- and monotherapy in category III B chronic pelvic pain syndrome (CPPS).
Tuğcu V; Taşçi AI; Fazlioğlu A; Gürbüz G; Ozbek E; Sahin S; Kurtuluş F; Cek M
Eur Urol; 2007 Apr; 51(4):1113-7; discussion 1118. PubMed ID: 17084960
[TBL] [Abstract][Full Text] [Related]
15. The beneficial effect of alfuzosin 10 mg once daily in 'real-life' practice on lower urinary tract symptoms (LUTS), quality of life and sexual dysfunction in men with LUTS and painful ejaculation.
Nickel JC; Elhilali M; Emberton M; Vallancien G;
BJU Int; 2006 Jun; 97(6):1242-6. PubMed ID: 16686719
[TBL] [Abstract][Full Text] [Related]
16. α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome.
Thakkinstian A; Attia J; Anothaisintawee T; Nickel JC
BJU Int; 2012 Oct; 110(7):1014-22. PubMed ID: 22471591
[TBL] [Abstract][Full Text] [Related]
17. [Combined therapy for the chronic pelvic pain syndrome].
Xu S; Qi G; Tang P; Li Y
Zhonghua Nan Ke Xue; 2004 Jun; 10(6):429-30, 433. PubMed ID: 15267206
[TBL] [Abstract][Full Text] [Related]
18. Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome.
Cheah PY; Liong ML; Yuen KH; Teh CL; Khor T; Yang JR; Yap HW; Krieger JN
Urology; 2004 Nov; 64(5):881-6. PubMed ID: 15533470
[TBL] [Abstract][Full Text] [Related]
19. [Retrospective analysis of the combined therapy of terazosin with chlormezanone for chronic prostatitis/chronic pelvic pain syndrome].
Yan S; Li HZ; Zhang XY; Li HJ
Zhonghua Nan Ke Xue; 2009 Aug; 15(8):717-20. PubMed ID: 19852273
[TBL] [Abstract][Full Text] [Related]
20. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial.
Alexander RB; Propert KJ; Schaeffer AJ; Landis JR; Nickel JC; O'Leary MP; Pontari MA; McNaughton-Collins M; Shoskes DA; Comiter CV; Datta NS; Fowler JE; Nadler RB; Zeitlin SI; Knauss JS; Wang Y; Kusek JW; Nyberg LM; Litwin MS;
Ann Intern Med; 2004 Oct; 141(8):581-9. PubMed ID: 15492337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
